Sangamo Therapeutics
SGMO
#9020
Rank
A$0.17 B
Marketcap
A$0.48
Share price
-5.28%
Change (1 day)
-64.75%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$32.87 Million. In 2024 the company made an earning of -A$0.14 Billion, an increase over its 2023 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion22.33%
2024 -A$0.14 Billion-17.27%
2023 -A$0.17 Billion-40.88%
2022 -A$0.29 Billion9.79%
2021 -A$0.26 Billion41.52%
2020 -A$0.19 Billion23.17%
2019 -A$0.15 Billion36.33%
2018 -A$0.11 Billion36.89%
2017 -A$79.65 Million-22.32%
2016 -A$0.11 Billion54.86%
2015 -A$66.22 Million75.62%
2014 -A$37.71 Million0.13%
2013 -A$37.66 Million
2011 -A$50.62 Million43.66%
2010 -A$35.24 Million28.52%
2009 -A$27.42 Million-23.55%
2008 -A$35.87 Million2.45%
2007 -A$35.01 Million19.5%
2006 -A$29.3 Million50.78%
2005 -A$19.43 Million75%
2004 -A$11.11 Million-33.25%
2003 -A$16.64 Million-62.27%
2002 -A$44.09 Million102.82%
2001 -A$21.74 Million23.21%
2000 -A$17.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.77 B-29,814.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.64 B-7,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.69 B-1,846.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-A$3.55 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.96 B-9,167.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.62 B-21,278.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.18 B-219.53%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.95 B-723.04%๐Ÿ‡บ๐Ÿ‡ธ USA